Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 19, 2015 11:19 AM ET

Diversified Financial Services

Company Overview of Constellation Bancorp

Company Overview

Constellation Bancorp was acquired by CoreStates Financial Corp. in 1993. Constellation Bancorp provides commercial banking services through its subsidiary Constellation Bank, N.A. The company was founded in 1985 and is based in Elizabeth, New Jersey.

68 Broad Street

Elizabeth, NJ 07201-2206

United States

Founded in 1985



Key Executives for Constellation Bancorp

Constellation Bancorp does not have any Key Executives recorded.

Constellation Bancorp Key Developments

Constellation Presents at 30th Annual Global Power Markets, Apr-14-2015 11:00 AM

Constellation Presents at 30th Annual Global Power Markets, Apr-14-2015 11:00 AM. Venue: Wynn Las Vegas, 3131 Las Vegas Blvd. South, Las Vegas, NV 89109, United States. Speakers: Andy Swaminathan, Senior Vice President, Portfolio Management and Strategy.

Constellation Presents at 16th Annual Financing US Power Conference, Oct-16-2014 09:15 AM

Constellation Presents at 16th Annual Financing US Power Conference, Oct-16-2014 09:15 AM. Venue: Crowne Plaza Times Square, New York, New York, United States. Speakers: Edward J. Quinn, President, Wholesale.

Constellation Expands Clinical Studies of CPI-0610

Constellation announced that it has initiated two additional clinical studies of its lead BET Inhibitor, CPI-0610. CPI-0610 has been progressing in a Phase 1 clinical trial in patients with lymphoma since September of 2013. As that trial continues, two new Phase 1 clinical trials of CPI-0610 were started in July of 2014. The first additional trial evaluates CPI-0610 in patients with multiple myeloma, while the second trial focuses on patients with acute leukemias or myelodysplastic syndrome. The expansion of the clinical evaluation of CPI-0610 to patients with these diseases is based on the high sensitivity of hematologic malignancies to BET inhibition in preclinical models, particularly in models of myeloma and acute leukemia. As a result of treating the first patients in both of these two new studies, Constellation earned a $1.5 MM milestone in its partnership with The Leukemia and Lymphoma Society (LLS). This external financial support from LLS enabled the expansion of the CPI-0610 clinical program into the three distinct indications being explored, with the hope of more rapidly and completely understanding which patients may benefit from this new approach to cancer treatment.

Similar Private Companies By Industry

Company Name Region
Forrest County Teachers Federal Credit Union United States
Northern Chautauqua Federal Credit Union United States
Upper Darby Belltelco Federal Credit Union United States
Bergen Federal Credit Union United States
Eli Lilly Federal Credit Union United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Constellation Bancorp, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at